Septina9 is a test that allows the early detection of colon cancer through a simple blood sample. The test does not require preparation, so it is not necessary to follow a specific diet or fasting. It presents a high sensitivity and specificity and detects the different types of colorectal cancer, regardless of their location. The sample for the performance of Septina9 is easily repeatable annually or biennially, which improves adherence by the patient to colon cancer screening programs. Septina9 is the only screening test for colorectal cancer in blood that is marked ΣE and approved by the FDA (Food and Drug Administration)
The analysis is indicated in:
Men and women over 50 years of age, who do not have other risk factors for colorectal cancer.
Analysis in pregnant women is not advised, because pregnancy may alter the result. The analysis does not replace the performance of colonoscopy, which remains the diagnostic test indicated for the identification of colon cancer and for the follow-up of people with personal and / or family history of the disease.
- Reservation: 30 € (included in the total amount).
- Amount: 185 €
IT IS INCLUDED
the performance of the test and its report is included.
TERMS OF SERVICE
Payment of the reservation can access the service described within three months.